Patent · US Active

Pharmaceutical compositions comprising a polypeptide comprising at least one CXXC motif and heterologous antigens and uses thereof

US9801927B2 · kind B2 · utility

0Cited by

1References

11Claims

0Family size

Assignees

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR
Universite Pierre Et Marie Curie (Paris 6) · FR
ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS (APHP) · FR
CONSEJO NACIONAL DE INVESTIGACIONES CIENTÍFICAS Y TÉCNICAS (CONICET) · AR
UNIVERSIDAD CATOLICA DE CORCOBA (UCC) · AR

Inventors

David Klatzmann · Paris, FR
Eliane Piaggio · Paris, FR
Hugo Lujan · San Pedro, AR

Key dates

Filing date	Mar 29, 2011
Grant date	Oct 31, 2017
Priority date	—
Expiry date	Jun 11, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S977/773
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to pharmaceutical compositions using a polypeptide comprising at least one CXXC motif, such as Giardia parasite's variable surface proteins (VSP) or a fragment thereof to raise by oral or mucosal vaccination an immune response against a heterologous selected antigen, such as tumor antigen, microbial antigen or other antigen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.